Beijing sainuopu Biotechnology Co., Ltd. (hereinafter referred to as sainuopu) was founded in 2014. It is an enterprise mainly engaged in R & D, production and sales of biochemical diagnostic reagents.            At present, sainuopu has obtained 108 medical device product registration certificates; Shanghai Lehe Biotechnology Co., Ltd., a wholly-owned subsidiary of sainuopu, is an enterprise mainly engaged in the research and development and production of immunodiagnostic reagents. Currently, it has obtained 7 registration certificates of immunofluorescent POCT products, and 14 immunofluorescence POCT projects are under registration and application The major scientific research projects applied by the Ministry of science and technology have been officially approved by the Ministry of science and technology, and POCT products of chemiluminescence platform have also been approved successfully. In the future,sainuopu will focus on building POCT products with large biochemical in vitro diagnostic reagents and immunofluorescence and luminescence platform!